(Q34398401)

English

A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4.

scientific article

Statements

A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4. (English)
Joseph F McCarville
John Z Sullivan-Bólyai

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit